A. Wolf et al., CYCLOSPORINE-A-INDUCED OXIDATIVE STRESS IN RAT HEPATOCYTES, The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1328-1334
In man the immunosuppressive drug Cyclosporine A (CsA) has been used s
uccessfully in organ transplantation and in the treatment of autoimmun
e disorders. The drug, however, causes side effects which occur mainly
in the kidney but also in the liver. The mechanisms leading to the he
patic side effects are not yet fully understood. Because reactive oxyg
en production is a common mechanism of drug toxicity, the goal of this
study was to evaluate whether CsA induces oxidative stress in rat liv
er cells. In primary rat hepatocyte 20-h cultures, CsA caused a concen
tration-dependent increase of free reactive oxygen species, thiobarbit
uric acid reactive substances, loss of protein thiols and decrease of
molar ratios of glutathione and glutathione disulfide in the range of
0 to 50 mu M CsA. The weakening or enforcement of the cellular glutath
ione state by the glutathione synthesis inhibitor buthionine sulfoximi
ne or the glutathione disulfide-reducing agent dithiothreitol either i
ncreased or inhibited the CsA cytotoxicity, as determined by lactate d
ehydrogenase release. CsA also decreased the level of endogenous antio
xidant ascorbic acid and increased its oxidation product dehydroascorb
ic acid. Supplementation of the cell cultures with ascorbic acid signi
ficantly reduced the CsA toxicity. The antioxidant lpha-tocopherol-pol
yethylene-glycol-1000-succinate partly decreased CsA-mediated reactive
oxygen species formation, totally decreased thiobarbituric acid react
ive substances formation, prevented the loss of protein-bound sulfhydr
yl groups and in addition totally inhibited the CsA cytotoxicity. The
present data provide good evidence that oxidative stress is part of th
e mechanism by which CsA causes toxicity in rat liver cells.